Patents by Inventor Xianyi ZHANG

Xianyi ZHANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230417936
    Abstract: A formulation for forming a styrene-based scintillator using light-directed additive manufacturing techniques includes a base monomer, a primary dye, a secondary dye, and a cationic photoinitiator. The base monomer includes one or more styrene-derivative monomers.
    Type: Application
    Filed: December 21, 2022
    Publication date: December 28, 2023
    Inventors: Jason Brodsky, Michael Joseph Ford, Alexandra Golobic, Connor Hook, Elaine Lee, Dominique Henry Porcincula, Xianyi Zhang, Caleb Chandler, Alan Sellinger
  • Publication number: 20230142248
    Abstract: The present disclosure relates to the field of medicine synthesis, and relates to a method for a racemic preparation of chiral h ?-amino acids and derivatives thereof, and in particular to a method for racemizing sitagliptin intermediates. where R1 is hydrogen, alkyl or aryl; R2 is hydrogen, alkyl or aryl; R3 is hydrogen, alkyl, aryl or acyl; R4 is alkyl, aryl, OR?, SR?, NHR? or NR?R?, wherein R?, R? are hydrogen, alkyl or aryl.
    Type: Application
    Filed: June 8, 2020
    Publication date: May 11, 2023
    Inventors: Hongliang Li, Xianyi Zhang, Zhaobo Gao
  • Publication number: 20210324217
    Abstract: An ink for forming a scintillator product includes a phenylated siloxane polymer having at least one functional group per molecule for crosslinking, a filler having a refractive index about matching a refractive index of the phenylated siloxane polymer, where the refractive indices are within about 5% of one another, a rheology modifier, and at least one fluorescent dye.
    Type: Application
    Filed: April 16, 2021
    Publication date: October 21, 2021
    Inventors: Andrew Neil Mabe, Jason Brodsky, Elaine Lee, Jeremy Lenhardt, Dominique Henry Porcincula, Xianyi Zhang
  • Patent number: 10023542
    Abstract: The present invention relates to the technical field of ibrutinib, particularly to the technical field of ibrutinib intermediate compounds and preparation methods thereof. The intermediate compounds are represented by formula A, wherein, the dotted line represents a double bond or a single bond between carbon and oxygen.
    Type: Grant
    Filed: April 21, 2015
    Date of Patent: July 17, 2018
    Assignee: Zhejiang Jiuzhou Pharmaceuticals Co., Ltd
    Inventors: Yunyu Hua, Xianyi Zhang, Hongjun Gao, Yuanqiang Li, Daqing Che
  • Publication number: 20170137386
    Abstract: The present invention relates to the technical field of ibrutinib, particularly to the technical field of ibrutinib intermediate compounds and preparation methods thereof. The intermediate compounds are represented by formula A, wherein, the dotted line represents a double bond or a single bond between carbon and oxygen.
    Type: Application
    Filed: April 21, 2015
    Publication date: May 18, 2017
    Applicant: ZHEJIANG JIUZHOU PHARMA SCIENCE & TECHNOLOGY CO., LTD.
    Inventors: Yunyu HUA, Xianyi ZHANG, Hongjun GAO, Yuanqiang LI, Daqing CHE
  • Patent number: 9394251
    Abstract: Disclosed are a silodosin intermediate and a preparation method thereof. The silodosin intermediate has the structure shown by the formula (A). X is hydrogen or bromide and R1 is hydrogen. The formyl group may be a group having the structure shown by the formula I. R7 is a protecting group of carboxyl, and R2 is 3-hydroxypropyl or a group having the structure shown by the formula II. W is a protecting group of hydroxyl. A compound of the formula (A) according to the present invention may further be used for preparing a compound having the structure shown by the formula (D). By means of the intermediate and the preparation method therefor provided by the present invention, high-purity optically pure silodosin can be obtained, and the optical purity is above 99%.
    Type: Grant
    Filed: July 27, 2012
    Date of Patent: July 19, 2016
    Assignee: Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    Inventors: Bin Zhang, Xiaowei Hu, Pucha Yan, Xianyi Zhang, Hongjun Gao, Yuanqiang Li, Daqing Che
  • Publication number: 20150148548
    Abstract: Disclosed are a silodosin intermediate and a preparation method thereof. The silodosin intermediate has the structure shown by the formula (A). X is hydrogen or bromide and R1 is hydrogen. The formyl group may be a group having the structure shown by the formula I. R7 is a protecting group of carboxyl, and R2 is 3-hydroxypropyl or a group having the structure shown by the formula II. W is a protecting group of hydroxyl. A compound of the formula (A) according to the present invention may further be used for preparing a compound having the structure shown by the formula (D). By means of the intermediate and the preparation method therefor provided by the present invention, high-purity optically pure silodosin can be obtained, and the optical purity is above 99%.
    Type: Application
    Filed: July 27, 2012
    Publication date: May 28, 2015
    Inventors: Bin Zhang, Xiaowei Hu, Pucha Yan, Xianyi Zhang, Hongjun Gao, Yuanqiang Li, Daqing Che
  • Patent number: 8829226
    Abstract: A new compound is provided, which is used for preparing lacosamide. A novel method for preparing lacosamide is also provided. During the reaction, iodomethane and silver oxide that are cost expensive are not used, nor a Pd-c catalyst is used, so the production cost is low, the raw materials and accessory materials are cheap and easily available, and the process is simple, so that industrial production is easy to realize; and moreover, the yield is high, and good economic efficiency can be achieved.
    Type: Grant
    Filed: January 28, 2011
    Date of Patent: September 9, 2014
    Assignee: Zhejiang Jiuzhou Pharmaceutical Co., Ltd
    Inventors: Xianyi Zhang, Shaoqing Ge, Daqing Che
  • Publication number: 20130066102
    Abstract: A new compound is provided, which is used for preparing lacosamide. A novel method for preparing lacosamide is also provided. During the reaction, iodomethane and silver oxide that are cost expensive are not used, nor a Pd-c catalyst is used, so the production cost is low, the raw materials and accessory materials are cheap and easily available, and the process is simple, so that industrial production is easy to realize; and moreover, the yield is high, and good economic efficiency can be achieved.
    Type: Application
    Filed: January 28, 2011
    Publication date: March 14, 2013
    Applicant: ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD
    Inventors: Xianyi Zhang, Shaoqing Ge, Daqing Che
  • Publication number: 20120283466
    Abstract: A new compound is provided, which is used for preparing lacosamide. A novel method for preparing lacosamide is also provided. During the reaction, iodomethane and silver oxide that are cost expensive are not used, nor a Pd-c catalyst is used, so the production cost is low, the raw materials and accessory materials are cheap and easily available, and the process is simple, so that industrial production is easy to realize; and moreover, the yield is high, and good economic efficiency can be achieved.
    Type: Application
    Filed: June 29, 2012
    Publication date: November 8, 2012
    Applicant: ZHEJIANG JIUZHOU PHARMACEUTICAL CO., LTD.
    Inventors: Xianyi ZHANG, Shaoqing GE, Daqing CHE